Skip to content

Neuroimaging mechanism study of Xueshuan Xinmaining on cognitive impairment in patients with lacunar infarction

Neuroimaging mechanism study of Xueshuan Xinmaining on cognitive impairment in patients with lacunar infarction

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046758
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-06-21
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lacunar infarction

Interventions

Sponsors

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Outpatients or inpatients aged 50-80 years and elderly residents of the community, education level >= 6 years; 2. There are objective lacunar infarcts detected by MRI, and the diameter of the lesion range from 215mm; 3. The score of Mini-Mental State Examination < 27, objective cognitive impairment; 4. No history or signs of stroke.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver, and renal insufficiency (Note: Severe liver insufficiency refers to ALT value > 2 times the upper limit of normal or AST value > 2 times the upper limit of normal; severe renal insufficiency refers to creatinine value > 1.5 times normal upper limit); 2. There is coagulopathy, systemic bleeding, a history of coagulopathy or systemic bleeding, a history of thrombocytopenia or neutropenia; 3. Patients with other mental and nervous system diseases and malignant tumors; 4. Those who have participated in other drug trials within 3 months before being selected; 5. Those who have poor compliance or are dying and cannot complete the course of treatment; 6. Use other drugs to improve cognitive function such as ChEIs or other psychotropic drugs in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Full-Dimensional Cognitive Function Score;Mini-Mental State Examination;Auditory Verbal Learning Test;Complex Figure Test;Verbal Fluency Test;Digit Span Test;Stroop Colour-Word Test;Trails Test;Activities of Daily Living;Geriatric Depression Scale;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Network Connections;Mean Diffusivity;Fractional Anisotropy;

Countries

China

Contacts

Public ContactWei Dongfeng

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

weidongfeng@aliyun.com+86 18301311686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026